{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,3,31]],"date-time":"2022-03-31T18:47:38Z","timestamp":1648752458356},"reference-count":27,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2011,7,1]],"date-time":"2011-07-01T00:00:00Z","timestamp":1309478400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Molecular and Cellular Cardiology"],"published-print":{"date-parts":[[2011,7]]},"DOI":"10.1016\/j.yjmcc.2011.04.004","type":"journal-article","created":{"date-parts":[[2011,4,25]],"date-time":"2011-04-25T00:55:17Z","timestamp":1303692917000},"page":"1-3","source":"Crossref","is-referenced-by-count":1,"title":["Is Raf1 a nexus for cardiac hypertrophic signaling in human disease?"],"prefix":"10.1016","volume":"51","author":[{"given":"Dominic P.","family":"Del Re","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junichi","family":"Sadoshima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.yjmcc.2011.04.004_bb0005","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1542\/peds.2009-3207","article-title":"Noonan syndrome: clinical features, diagnosis, and management guidelines","volume":"126","author":"Romano","year":"2010","journal-title":"Pediatrics"},{"issue":"8","key":"10.1016\/j.yjmcc.2011.04.004_bb0010","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1002\/humu.20748","article-title":"The RAS\/MAPK syndromes: novel roles of the RAS pathway in human genetic disorders","volume":"29","author":"Aoki","year":"2008","journal-title":"Hum Mutat"},{"issue":"3","key":"10.1016\/j.yjmcc.2011.04.004_bb0015","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.gde.2009.04.001","article-title":"The RASopathies: developmental syndromes of Ras\/MAPK pathway dysregulation","volume":"19","author":"Tidyman","year":"2009","journal-title":"Curr Opin Genet Dev"},{"issue":"4","key":"10.1016\/j.yjmcc.2011.04.004_bb0020","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1038\/ng772","article-title":"Mutations in PTPN11, encoding the protein tyrosine phosphatase SHP-2, cause Noonan syndrome","volume":"29","author":"Tartaglia","year":"2001","journal-title":"Nat Genet"},{"issue":"6","key":"10.1016\/j.yjmcc.2011.04.004_bb0025","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/S0968-0004(03)00091-4","article-title":"The 'Shp'ing news: SH2 domain-containing tyrosine phosphatases in cell signaling","volume":"28","author":"Neel","year":"2003","journal-title":"Trends Biochem Sci"},{"issue":"1","key":"10.1016\/j.yjmcc.2011.04.004_bb0030","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1038\/ng1926","article-title":"Germline gain-of-function mutations in SOS1 cause Noonan syndrome","volume":"39","author":"Roberts","year":"2007","journal-title":"Nat Genet"},{"issue":"1","key":"10.1016\/j.yjmcc.2011.04.004_bb0035","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1038\/ng1939","article-title":"Gain-of-function SOS1 mutations cause a distinctive form of Noonan syndrome","volume":"39","author":"Tartaglia","year":"2007","journal-title":"Nat Genet"},{"issue":"8","key":"10.1016\/j.yjmcc.2011.04.004_bb0040","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1038\/ng2073","article-title":"Gain-of-function RAF1 mutations cause Noonan and LEOPARD syndromes with hypertrophic cardiomyopathy","volume":"39","author":"Pandit","year":"2007","journal-title":"Nat Genet"},{"issue":"8","key":"10.1016\/j.yjmcc.2011.04.004_bb0045","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1038\/ng2078","article-title":"Germline gain-of-function mutations in RAF1 cause Noonan syndrome","volume":"39","author":"Razzaque","year":"2007","journal-title":"Nat Genet"},{"issue":"3","key":"10.1016\/j.yjmcc.2011.04.004_bb0050","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1038\/ng1748","article-title":"Germline KRAS mutations cause Noonan syndrome","volume":"38","author":"Schubbert","year":"2006","journal-title":"Nat Genet"},{"issue":"1","key":"10.1016\/j.yjmcc.2011.04.004_bb0055","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1038\/ng.497","article-title":"A restricted spectrum of NRAS mutations causes Noonan syndrome","volume":"42","author":"Cirstea","year":"2010","journal-title":"Nat Genet"},{"issue":"9","key":"10.1016\/j.yjmcc.2011.04.004_bb0060","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1038\/ng.425","article-title":"Mutation of SHOC2 promotes aberrant protein N-myristoylation and causes Noonan-like syndrome with loose anagen hair","volume":"41","author":"Cordeddu","year":"2009","journal-title":"Nat Genet"},{"issue":"10","key":"10.1016\/j.yjmcc.2011.04.004_bb0065","doi-asserted-by":"crossref","first-page":"6785","DOI":"10.1074\/jbc.M513068200","article-title":"PTPN11 (Shp2) mutations in LEOPARD syndrome have dominant negative, not activating, effects","volume":"281","author":"Kontaridis","year":"2006","journal-title":"J Biol Chem"},{"issue":"2","key":"10.1016\/j.yjmcc.2011.04.004_bb0070","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1086\/341528","article-title":"Grouping of multiple-lentigines\/LEOPARD and Noonan syndromes on the PTPN11 gene","volume":"71","author":"Digilio","year":"2002","journal-title":"Am J Hum Genet"},{"issue":"8","key":"10.1016\/j.yjmcc.2011.04.004_bb0075","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1136\/jmg.39.8.571","article-title":"PTPN11 mutations in LEOPARD syndrome","volume":"39","author":"Legius","year":"2002","journal-title":"J Med Genet"},{"issue":"1","key":"10.1016\/j.yjmcc.2011.04.004_bb0080","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1111\/j.1442-200X.1996.tb03445.x","article-title":"Hypertrophic cardiomyopathy in Noonan syndrome","volume":"38","author":"Nishikawa","year":"1996","journal-title":"Acta Paediatr Jpn"},{"issue":"6","key":"10.1016\/j.yjmcc.2011.04.004_bb0085","doi-asserted-by":"crossref","first-page":"e1325","DOI":"10.1542\/peds.2006-0211","article-title":"The spectrum of cardiac anomalies in Noonan syndrome as a result of mutations in the PTPN11 gene","volume":"119","author":"Sznajer","year":"2007","journal-title":"Pediatrics"},{"issue":"39","key":"10.1016\/j.yjmcc.2011.04.004_bb0090","doi-asserted-by":"crossref","first-page":"23173","DOI":"10.1074\/jbc.270.39.23173","article-title":"Ventricular expression of a MLC-2v-ras fusion gene induces cardiac hypertrophy and selective diastolic dysfunction in transgenic mice","volume":"270","author":"Hunter","year":"1995","journal-title":"J Biol Chem"},{"issue":"23","key":"10.1016\/j.yjmcc.2011.04.004_bb0095","doi-asserted-by":"crossref","first-page":"6341","DOI":"10.1093\/emboj\/19.23.6341","article-title":"The MEK1-ERK1\/2 signaling pathway promotes compensated cardiac hypertrophy in transgenic mice","volume":"19","author":"Bueno","year":"2000","journal-title":"EMBO J"},{"issue":"35","key":"10.1016\/j.yjmcc.2011.04.004_bb0100","doi-asserted-by":"crossref","first-page":"14074","DOI":"10.1073\/pnas.0610906104","article-title":"Genetic inhibition of cardiac ERK1\/2 promotes stress-induced apoptosis and heart failure but has no effect on hypertrophy in vivo","volume":"104","author":"Purcell","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6","key":"10.1016\/j.yjmcc.2011.04.004_bb0105","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1161\/01.CIR.0000138190.50127.6A","article-title":"Raf-1 kinase is required for cardiac hypertrophy and cardiomyocyte survival in response to pressure overload","volume":"110","author":"Harris","year":"2004","journal-title":"Circulation"},{"issue":"7","key":"10.1016\/j.yjmcc.2011.04.004_bb0110","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1172\/JCI200420317","article-title":"Cardiac-specific disruption of the c-raf-1 gene induces cardiac dysfunction and apoptosis","volume":"114","author":"Yamaguchi","year":"2004","journal-title":"J Clin Invest"},{"issue":"11","key":"10.1016\/j.yjmcc.2011.04.004_bb0115","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1038\/nrm1498","article-title":"The RAF proteins take centre stage","volume":"5","author":"Wellbrock","year":"2004","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"3","key":"10.1016\/j.yjmcc.2011.04.004_bb0120","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.cardiores.2004.01.021","article-title":"Calcineurin-NFAT signaling regulates the cardiac hypertrophic response in coordination with the MAPKs","volume":"63","author":"Molkentin","year":"2004","journal-title":"Cardiovasc Res"},{"issue":"7299","key":"10.1016\/j.yjmcc.2011.04.004_bb0125","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1038\/nature09005","article-title":"Patient-specific induced pluripotent stem-cell-derived models of LEOPARD syndrome","volume":"465","author":"Carvajal-Vergara","year":"2010","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.yjmcc.2011.04.004_bb0130","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1172\/JCI44929","article-title":"MEK-ERK pathway modulation ameliorates disease phenotypes in a mouse model of Noonan syndrome associated with the Raf1L613V mutation","volume":"121","author":"Wu","year":"2011","journal-title":"J Clin Invest"},{"issue":"1","key":"10.1016\/j.yjmcc.2011.04.004_bb0135","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.yjmcc.2011.03.001","article-title":"Cyclosporine attenuates cardiomyocyte hypertrophy induced by RAF1 mutants in Noonan and LEOPARD syndromes","volume":"55","author":"Dhandapany","year":"2011","journal-title":"J Mol Cell Cardiol"}],"container-title":["Journal of Molecular and Cellular Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022282811001611?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022282811001611?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,3]],"date-time":"2018-12-03T00:54:52Z","timestamp":1543798492000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022282811001611"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,7]]},"references-count":27,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,7]]}},"alternative-id":["S0022282811001611"],"URL":"https:\/\/doi.org\/10.1016\/j.yjmcc.2011.04.004","relation":{},"ISSN":["0022-2828"],"issn-type":[{"value":"0022-2828","type":"print"}],"subject":[],"published":{"date-parts":[[2011,7]]}}}